Genprex, Inc.
GNPX
Rank in Stocks
#32926
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its... Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically designed to target both non-small cell lung cancer and small cell lung cancer. In addition, Genprex is progressing GPX-002, another gene therapy at the preclinical stage, intended for the management of diabetes. The company was established in 2009 and operates from its corporate headquarters located in Austin, Texas.
Share Price
$2.06
Last synced: 2026-11-09
Market Cap
$1.04M
Change (1 day)
-0.48%
Change (1 year)
-97.69%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Genprex, Inc. (GNPX)
Category
Healthcare
EPS for Genprex, Inc. (GNPX)
EPS as of June 2026 TTM: $-158.78
According to Genprex, Inc.'s latest financial reports, its current EPS (TTM) is $-158.78. At the end of 2025 the company had an EPS of $-382.80, an increase over its 2024 EPS of $-5.87K.
EPS history for Genprex, Inc. from 2015 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-158.78 | -58.52% |
| 2025 | $-382.80 | -93.48% |
| 2024 | $-5.87K | -76.35% |
| 2023 | $-24.84K | 14.04% |
| 2022 | $-21.78K | 12.82% |
| 2021 | $-19.31K | -13.03% |
| 2020 | $-22.20K | -24.25% |
| 2019 | $-29.30K | -25.94% |
| 2018 | $-39.57K | 211.43% |
| 2017 | $-12.71K | -24.51% |
| 2016 | $-16.83K | -34.19% |
| 2015 | $-25.58K | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -109.86% |
US
|
|
| $-7.07 | -95.55% |
US
|
|
| $-5.29 | -96.67% |
AU
|
|
| $12.88 | -108.11% |
BE
|
|
| $21.56 | -113.58% |
NL
|
Questions about Genprex, Inc.'s earnings per share (EPS)
What is Genprex, Inc.'s earnings per share (EPS)?
Genprex, Inc.'s earnings per share (EPS) over the last twelve months is $-158.78, as of Jun 2026.
What was Genprex, Inc.'s earnings per share (EPS) in 2025?
In 2025, Genprex, Inc.'s earnings per share (EPS) was $-382.80, compared with $-5.87K in 2024.
How has Genprex, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Genprex, Inc.'s earnings per share (EPS) was highest in 2025 ($-382.80) and lowest in 2023 ($-24.84K).
How does Genprex, Inc.'s earnings per share (EPS) compare with similar companies?
Genprex, Inc.'s earnings per share (EPS) ($-158.78) is lower than that of all 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.